D
Translational Development Acquisition Corp. TDAC
$10.45 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 970.40% 725.05% 390.92% 85.40% --
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -354,543.75% -237,431.25% -244,100.00% -- --
Change in Net Operating Assets -1,846.64% -24,815.00% -21,864.00% -22,096.67% --
Cash from Operations -3,114.81% -- -1,083,000.00% -425,650.00% --
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -12.41% 380.71% 961.43% -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 91,614.67% -- -- -- --
Cash from Financing 66,700.04% 250,532.29% 501,264.57% -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -179.76% -152.72% 387.07% 218,150.00% --